Suppr超能文献

内源性DFF40/CAD核酸内切酶缺陷会损害半胱天冬酶依赖性细胞死亡过程中的寡核小体DNA水解:人胶质母细胞瘤细胞的共同特征。

An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

作者信息

Sánchez-Osuna María, Martínez-Escardó Laura, Granados-Colomina Carla, Martínez-Soler Fina, Pascual-Guiral Sònia, Iglesias-Guimarais Victoria, Velasco Roser, Plans Gerard, Vidal Noemi, Tortosa Avelina, Barcia Carlos, Bruna Jordi, Yuste Victor J

机构信息

Cell Death, Senescence and Survival group, Department of Biochemistry and Molecular Biology and Institute of Neurosciences, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain (M.S.-O., L.M.-E., C.G.-C., S.P.-G., V.I.-G., V.J.Y.); Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (C.I.B.E.R.N.E.D.), Barcelona, Spain (M.S.-O., V.I.-G., V.J.Y.); Department of Basic Nursing, Institut d'Investigació Biomèdica de Bellvitge-Universitat de Barcelona, Barcelona, Spain (F.M.-S., A.T.); Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-I.C.O Duran i Reynals, Barcelona, Spain (R.V., G.P., N.V., J.B.); Group of Neuroplasticity and Regeneration (C.I.B.E.R.N.E.D.), Department of Cell Biology, Physiology and Immunology & Institute of Neurosciences, Universitat Autònoma de Barcelona, Barcelona, Spain (R.V., J.B.); Neuropathology Institute, Hospital Universitari de Bellvitge, Barcelona, Spain (N.V.); Neuro-Immunity Group, Department of Biochemistry and Molecular Biology and Institute of Neurosciences, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain (C.B.).

出版信息

Neuro Oncol. 2016 Jul;18(7):950-61. doi: 10.1093/neuonc/nov315. Epub 2016 Jan 10.

Abstract

BACKGROUND

Glioblastoma (GBM) or grade IV astrocytoma is one of the most devastating human cancers. The loss of DFF40/CAD, the key endonuclease that triggers oligonucleosomal DNA fragmentation during apoptosis, has been linked to genomic instability and cell survival after radiation. Despite the near inevitability of GBM tumor recurrence after treatment, the relationship between DFF40/CAD and GBM remains unexplored.

METHODS

We studied the apoptotic behavior of human GBM-derived cells after apoptotic insult. We analyzed caspase activation and the protein levels and subcellular localization of DFF40/CAD apoptotic endonuclease. DFF40/CAD was also evaluated in histological sections from astrocytic tumors and nontumoral human brain.

RESULTS

We showed that GBM cells undergo incomplete apoptosis without generating oligonucleosomal DNA degradation despite the correct activation of executioner caspases. The major defect of GBM cells relied on the improper accumulation of DFF40/CAD at the nucleoplasmic subcellular compartment. Supporting this finding, DFF40/CAD overexpression allowed GBM cells to display oligonucleosomal DNA degradation after apoptotic challenge. Moreover, the analysis of histological slices from astrocytic tumors showed that DFF40/CAD immunoreactivity in tumoral GFAP-positive cells was markedly reduced when compared with nontumoral samples.

CONCLUSIONS

Our data highlight the low expression levels of DFF40/CAD and the absence of DNA laddering as common molecular traits in GBM. These findings could be of major importance for understanding the malignant behavior of remaining tumor cells after radiochemotherapy.

摘要

背景

胶质母细胞瘤(GBM)或IV级星形细胞瘤是最具毁灭性的人类癌症之一。DFF40/CAD是在凋亡过程中触发寡核小体DNA片段化的关键核酸内切酶,其缺失与基因组不稳定和放疗后的细胞存活有关。尽管GBM肿瘤治疗后几乎不可避免地会复发,但DFF40/CAD与GBM之间的关系仍未得到探索。

方法

我们研究了人源GBM细胞在凋亡刺激后的凋亡行为。我们分析了半胱天冬酶的激活以及DFF40/CAD凋亡核酸内切酶的蛋白水平和亚细胞定位。还在星形细胞瘤和非肿瘤性人脑的组织切片中评估了DFF40/CAD。

结果

我们发现,尽管执行半胱天冬酶被正确激活,但GBM细胞经历不完全凋亡,且未产生寡核小体DNA降解。GBM细胞的主要缺陷在于DFF40/CAD在核质亚细胞区室中积累不当。支持这一发现的是,DFF40/CAD过表达使GBM细胞在凋亡刺激后能够显示寡核小体DNA降解。此外,对星形细胞瘤组织切片的分析表明,与非肿瘤样本相比,肿瘤性GFAP阳性细胞中的DFF40/CAD免疫反应性明显降低。

结论

我们的数据突出了DFF40/CAD低表达水平和缺乏DNA梯带作为GBM常见分子特征。这些发现对于理解放化疗后残留肿瘤细胞的恶性行为可能具有重要意义。

相似文献

7
Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.
Cancers (Basel). 2021 Nov 8;13(21):5579. doi: 10.3390/cancers13215579.
9
Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.
Mol Cell. 2004 May 21;14(4):531-9. doi: 10.1016/s1097-2765(04)00258-8.
10
DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis.
Toxicology. 2019 Oct 1;426:152255. doi: 10.1016/j.tox.2019.152255. Epub 2019 Aug 8.

引用本文的文献

1
CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer.
Cell Death Dis. 2025 Aug 23;16(1):641. doi: 10.1038/s41419-025-07964-8.
2
DNA fragmentation factor 40-based therapeutic approaches for cancer: a review article.
Med Oncol. 2024 Oct 14;41(11):264. doi: 10.1007/s12032-024-02511-5.
5
The dual role of the CD95 and CD95L signaling pathway in glioblastoma.
Front Immunol. 2022 Nov 24;13:1029737. doi: 10.3389/fimmu.2022.1029737. eCollection 2022.
6
Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.
Mol Cell Biochem. 2022 Sep;477(9):2213-2233. doi: 10.1007/s11010-022-04433-0. Epub 2022 Apr 22.
7
Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.
Cancers (Basel). 2021 Nov 8;13(21):5579. doi: 10.3390/cancers13215579.
8
DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.
Biotechnol Lett. 2021 Oct;43(10):1967-1976. doi: 10.1007/s10529-021-03178-y. Epub 2021 Sep 5.
9
The role of the DFF40/CAD endonuclease in genomic stability.
Apoptosis. 2021 Feb;26(1-2):9-23. doi: 10.1007/s10495-020-01649-7. Epub 2021 Jan 2.
10
Two Simple Methods for Optimizing the Production of "Difficult-to-Express" GnRH-DFF40 Chimeric Protein.
Adv Pharm Bull. 2019 Aug;9(3):423-431. doi: 10.15171/apb.2019.050. Epub 2019 Aug 1.

本文引用的文献

1
An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death.
J Biol Chem. 2015 Aug 21;290(34):20841-20855. doi: 10.1074/jbc.M115.644179. Epub 2015 Jun 29.
2
Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.
J Clin Neurosci. 2015 Aug;22(8):1219-26. doi: 10.1016/j.jocn.2015.02.008. Epub 2015 May 6.
3
Personalized medicine for gliomas.
Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S89-95. doi: 10.4103/2152-7806.151351. eCollection 2015.
4
Glioma in 2014: unravelling tumour heterogeneity-implications for therapy.
Nat Rev Clin Oncol. 2015 Feb;12(2):69-70. doi: 10.1038/nrclinonc.2014.223. Epub 2015 Jan 6.
5
Old, new and emerging functions of caspases.
Cell Death Differ. 2015 Apr;22(4):526-39. doi: 10.1038/cdd.2014.216. Epub 2014 Dec 19.
6
Rethinking glioma treatment strategy.
Oncotarget. 2014 Oct 30;5(20):9532-3. doi: 10.18632/oncotarget.2619.
9
Oxidized extracellular DNA as a stress signal that may modify response to anticancer therapy.
Cancer Lett. 2015 Jan 1;356(1):22-33. doi: 10.1016/j.canlet.2013.09.005. Epub 2013 Sep 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验